AQUESTIVE THERAPEUTICS INC. - COMMON STOCK

3.0900

05-February-25 16:45:00

15 minutes delayed

Stocks

+0.0200

+0.65%

Today's range

3.0200 - 3.1290

ISIN

N/A

Source

NASDAQ

Aquestive Therapeutics to Host Investor & Analyst Virtual Epinephrine Drug Delivery R&D Event on March 25 at 9:00 a.m. ET

05 Mar 2021 07:00:00 By Nasdaq GlobeNewswire
Aquestive Therapeutics Reaffirms Near-Term NDA Resubmission for Libervant™ (diazepam) Buccal Film Following FDA Feedback

25 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
Aquestive Therapeutics to Announce Fourth Quarter and Year End 2020 Financial Results and Recent Business Highlights on March 9 and Host Conference Call on March 10 at 8:00 a.m. ET

17 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors

09 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
Aquestive Therapeutics Appoints Mark Lepore, MD, as Chief Medical Officer for Allergy

28 Jan 2021 07:30:00 By Nasdaq GlobeNewswire
Aquestive Therapeutics Provides Business Update

07 Jan 2021 07:30:00 By Nasdaq GlobeNewswire
Aquestive Therapeutics to Present at Two Upcoming Investor Conferences

04 Jan 2021 07:30:00 By Nasdaq GlobeNewswire

<<
<
3
4
5
6
7
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.